ASCO 2021 | Improving the stratification of prostate cancer
Alistair Grey
• 1 Jun 2021
Alistair Grey, FRCS (Urol), University College London, London, UK, discusses the ongoing efforts in prostate cancer to improve stratification using newer biomarkers. A more accurate stratification model may enable less invasive treatment of men with less aggressive disease. Dr Grey also highlights the potential of improved stratification to identify more patients suitable for active surveillance. This interview took place at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.
Disclosures
Alistair Grey, FRCS (Urol) has received travel and accommodation for training in the use of irreversible electroporation from Angiodynamics Ltd who manufacture the Nanoknife.
